Ørsted says Mads Nipper will be replaced by deputy chief Rasmus ErrboeRead More
You might also be interested in reading Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary….
